Showing results (1341-1350 of 1,434) with videos related to

Sort By:
Pageof 144
Journal of Vascular Research|April 11, 2021
Vascular Patterning as Integrative Readout of Complex Molecular and Physiological Signaling by VESsel GENeration AnalysisMark Lagatuz, Ruchi J Vyas, Marina Predovic, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 22, 2024
How long is long enough? An international survey exploring practice variations on the recommended duration of maintenance therapy with PARP inhibitors in patients with platinum sensitive recurrent ovarian cancer and long-term outcomesLucy Haggstrom, Yeh Chen Lee, Clare Scott, et al.
JAMA Oncology|November 18, 2017
Association of Ipilimumab With Safety and Antitumor Activity in Women With Metastatic or Recurrent Human Papillomavirus-Related Cervical CarcinomaStephanie Lheureux, Marcus O Butler, Blaise Clarke, et al.
The Lancet. Oncology|May 4, 2020
Rucaparib for patients with platinum-sensitive, recurrent ovarian carcinoma (ARIEL3): post-progression outcomes and updated safety results from a randomised, placebo-controlled, phase 3 trialJonathan A Ledermann, Amit M Oza, Domenica Lorusso, et al.
Cancer Medicine|September 22, 2021
Maintenance treatment with rucaparib for recurrent ovarian carcinoma in ARIEL3, a randomized phase 3 trial: The effects of best response to last platinum-based regimen and disease at baseline on efficacy and safetyAna Oaknin, Amit M Oza, Domenica Lorusso, et al.
Journal for Immunotherapy of Cancer|August 6, 2020
An open-label, phase II multicohort study of an oral hypomethylating agent CC-486 and durvalumab in advanced solid tumorsKirsty Taylor, Helen Loo Yau, Ankur Chakravarthy, et al.
The New England Journal of Medicine|December 30, 2011
A phase 3 trial of bevacizumab in ovarian cancerTimothy J Perren, Ann Marie Swart, Jacobus Pfisterer, et al.
Plos One|February 16, 2021
Prospective observational study and serosurvey of SARS-CoV-2 infection in asymptomatic healthcare workers at a Canadian tertiary care centerVictor H Ferreira, Andrzej Chruscinski, Vathany Kulasingam, et al.
Heart Rhythm O2|March 6, 2023
Hybrid epicardial-endocardial ablation for long-standing persistent atrial fibrillation: A subanalysis of the CONVERGE TrialDavid B DeLurgio, Christopher Blauth, Michael E Halkos, et al.
Cell Reports|September 8, 2021
Topoisomerase I inhibition and peripheral nerve injury induce DNA breaks and ATF3-associated axon regeneration in sensory neuronsYung-Chih Cheng, Andrew Snavely, Lee B Barrett, et al.
Pageof 144